V61M (p.Val61Met) variant of CMA1 (Chymase)
V61M (p.Val61Met) in CMA1 (Chymase) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.91 / 1. The record also includes structural context.
V61M (p.Val61Met) variant details
- p.Val61Met
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.906
- ESM-1b 1.00
- AlphaMissense 0.79
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available